在中国和日本的多细胞血症患者中,罗佩干扰素阿尔法-2b的人口药理动力学-药理动力学和暴露-反应

相关实验视频

Updated: May 15, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

357

Albert Qin1, Kazuya Shimoda2, Shanshan Suo3

  • 1Medical Research & Clinical Operations, PharmaEssentia Corporation, Taipei, Taiwan.

Pharmacology research & perspectives
|May 2, 2025
PubMed
概括

罗佩干扰素α-2b (ropeg) 通过影响血液学参数和JAK2V617F等位基因负担,有效地管理多细胞血病 (PV). 这项研究澄清了它的药理动力学-药理动力学,显示了快速剂量和持续疾病修饰的更快的血红素降低.

关键词:
在JAK2V617F等位基因负担中,罗佩格干扰素α-2b (罗佩格) 的使用完整的血液学反应 (CHR)暴露 - 反应 (E-R)病毒性多细胞血症 (PV)人口的药理动力学-药理动力学 (PopPK-PD)

更多相关视频

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.8K

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
202
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
52